Evidence map›Paper›PMID 30410440›Full record

ArticleFrontiers in pharmacology2018

Sweroside Alleviated Aconitine-Induced Cardiac Toxicity in H9c2 Cardiomyoblast Cell Line.

Li-Qun Ma, You Yu, Hui Chen, Mei Li, Awais Ihsan, Hai-Ying Tong, Xian-Ju Huang, Yue Gao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Simultaneous Determination of Five Iridoids ofMolecules (Basel, Switzerland) · 2023
    Article
  11. Molecules (Basel, Switzerland) · 2023
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Anshen Buxin Liuwei Pill, a Mongolian Medicinal Formula, Could Protect HEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  17. Article
  18. Review
  19. Frontiers in pharmacology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Li-Qun MaCollege of Life Sciences, South-Central University for Nationalities, Wuhan, China.
You YuCollege of Pharmacy, South-Central University for Nationalities, Wuhan, China.
Hui ChenCollege of Pharmacy, South-Central University for Nationalities, Wuhan, China.
Mei LiCollege of Pharmacy, South-Central University for Nationalities, Wuhan, China.
Awais IhsanDepartment of Biosciences, COMSATS University Islamabad (CUI), Sahiwal, Pakistan.
Hai-Ying TongSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Xian-Ju HuangCollege of Pharmacy, South-Central University for Nationalities, Wuhan, China.
Yue GaoDepartment of Pharmacology and Toxicology, Beijing Institute of Radiation Medicine, Beijing, China.
South Central University for Nationalities · CNBeijing Radiation Center · CNBeijing University of Chinese Medicine · CNCOMSATS University Islamabad · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aconitine is the main bioactive ingredient of Aconitum plants, which are well-known botanical herbs in China. Aconitine is also notorious for its high cardiotoxicity, as it can induce life-threatening ventricular arrhythmias. Unfortunately, there are few effective antidotes to aconitine toxicity. This study aimed to evaluate the potent protective effects of the ingredients from

Indexed as

aconitinecalcium overloadcardiac toxicityreactive oxygen speciessweroside

Identifiers

PMID30410440
PMCPMC6209819
OpenAlexW2898353163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.